Low-calcium diets increase both production and clearance of 1,25-dihydroxyvitamin D3 in rats
- PMID: 2154934
- DOI: 10.1152/ajpendo.1990.258.2.E282
Low-calcium diets increase both production and clearance of 1,25-dihydroxyvitamin D3 in rats
Abstract
Administration of large doses of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] to animals induces 1,25(OH)2D3 side-chain oxidative pathways. This study determined if the elevated plasma 1,25(OH)2D3 seen in rats fed low-Ca diets is associated not only with an increased production rate (PR) but also with an increased metabolic clearance rate (MCR) of the hormone. In vitamin D-replete rats fed a Ca-deficient diet for 3-4 wk, the PR increased 21-fold, plasma levels 15-fold, and the MCR by 37%. The increased MCR in Ca-deficient rats was associated with a 48% increase in hepatic microsomal UDP glucuronyl transferase enzyme activity, whereas 1,25(OH)2D3 catabolism by homogenates of liver and small intestinal mucosa was unchanged. In contrast to the effects of low-Ca diets, acute (7 h) pharmacological elevation of plasma 1,25(OH)2D3 to 1.5 ng/ml in normal rats did not influence the MCR. Thus chronically elevated 1,25(OH)2D3 levels are necessary to stimulate clearance. In conclusion, 1,25(OH)2D3 clearance in rats can be stimulated not only by chronic pharmacological doses of 1,25(OH)2D3 but also by the physiological stimulus of a low-Ca diet. Hence, plasma 1,25(OH)2D3 levels can be regulated by changes in both PR and MCR.
Similar articles
-
Metabolism of 25-hydroxyvitamin D3 in rats: low-calcium diet vs. calcitriol infusion.Am J Physiol. 1992 Mar;262(3 Pt 1):E359-67. doi: 10.1152/ajpendo.1992.262.3.E359. Am J Physiol. 1992. PMID: 1550228
-
Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.Endocrinology. 1982 Jun;110(6):1983-8. doi: 10.1210/endo-110-6-1983. Endocrinology. 1982. PMID: 6978809
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Adaptation of middle aged rats to long-term restriction of dietary vitamin D and calcium.Arch Biochem Biophys. 1985 Nov 1;242(2):464-9. doi: 10.1016/0003-9861(85)90231-0. Arch Biochem Biophys. 1985. PMID: 3840668
-
Metabolism of 1,25-dihydroxyvitamin D3.Physiol Rev. 1984 Apr;64(2):478-504. doi: 10.1152/physrev.1984.64.2.478. Physiol Rev. 1984. PMID: 6324253 Review.
Cited by
-
Metabolic effects of thiazide and 1,25-(OH)2 vitamin D in postmenopausal osteoporosis.Osteoporos Int. 1993 Jul;3(4):209-14. doi: 10.1007/BF01623678. Osteoporos Int. 1993. PMID: 8338977 Clinical Trial.
-
The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism.Endocrine. 1999 Apr;10(2):97-103. doi: 10.1385/ENDO:10:2:97. Endocrine. 1999. PMID: 10451217
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials